Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 3, 2025
Event: Regulation FD Disclosure regarding upcoming investor meetings scheduled between March 3, 2025, and March 31, 2025.
Key Financial Metrics
This filing does not report historical revenue, profit, cash flow, margins, debt, or liquidity figures. It exclusively provides forward-looking guidance for the fiscal year ending December 31, 2025 (FY 2025).
| Metric | Value (FY 2025 Guidance) |
|---|---|
| Diluted EPS (GAAP) | Approximately $15.88 |
| Adjusted EPS (Non-GAAP) | Approximately $16.25 |
Material Changes
The filing states that the FY 2025 guidance is consistent with the guidance previously issued in a press release dated February 11, 2025. No material changes to prior guidance are reported in this document.
Guidance, Outlook, and Risks
- Guidance Reaffirmation: Management intends to reaffirm FY 2025 guidance of approximately $15.88 GAAP EPS and $16.25 Adjusted EPS.
- Non-GAAP Reconciliation: The difference between GAAP and Adjusted EPS is driven by the amortization of identifiable intangibles ($0.49) and a cumulative net tax impact of non-GAAP adjustments ($0.12).
- Management Commentary: Adjusted EPS is used by management to analyze core operating performance, plan, and determine incentive compensation, though it is not a substitute for GAAP measures.
- Risks: The filing includes a standard cautionary statement noting that forward-looking statements are subject to risks, uncertainties, and assumptions detailed in the "Risk Factors" section of other SEC filings.
Investor Verification Checklist
- Verify the specific date and time of the upcoming investor meetings between March 3 and March 31, 2025.
- Review the February 11, 2025 press release to confirm the original context of the $15.88/$16.25 EPS guidance.
- Examine the "Risk Factors" section in Humana's most recent 10-K or 10-Q to understand the specific uncertainties affecting the FY 2025 outlook.
- Confirm the reconciliation details for Adjusted EPS in future earnings releases to ensure consistency with the $0.49 amortization and $0.12 tax impact cited here.